Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Update on Offer for Subscription

22 Jun 2021 17:22

RNS Number : 7588C
Amati AIM VCT PLC
22 June 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

AMATI AIM VCT PLC

LEI: 213800HAEDBBK9RWCD25

22 June 2021

Update on Offer for Subscription

Following the announcement made on 12 April 2021, the Board of Amati AIM VCT PLC (the "Company") has discussed the size and structure of the proposed offer for subscription (the "Offer") with the Company's investment manager. Having considered the deployment of funds over the last six months and the current pipeline of investment opportunities, the Company is seeking to raise £30 million over a 12 month period from the date of publication of the prospectus related to the Offer. Initially, subscriptions will be accepted for the 2021/2022 tax year only.

The Directors will also have discretion to utilise an over-allotment facility of up to £30 million, either in whole or in part. This facility will only be utilised if sufficient Qualifying Investments have been made from the initial proceeds of the Offer and the investment manager has identified further investment opportunities. In this event, the Company may also accept applications in respect of the 2022/2023 tax year.

Subject to certain conditions, the Board intends to open the Offer to existing shareholders for a limited period prior to opening the Offer to new investors.

The prospectus, which will contain the full details and terms and conditions of the Offer, will be available from www.amatiglobal.com as soon as the Offer is launched, which is expected to be at the end of July 2021. A further announcement will be made when the prospectus is available.

Further information

For further information please contact Samantha Dalby on 0131 503 9115 or email: info@amatiglobal.com.

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKKAAFXFEFA
Date   Source Headline
10th Apr 20188:14 amRNSDirector/PDMR Shareholding
9th Apr 20185:19 pmRNSIssue of Equity
4th Apr 20185:10 pmRNSNet Asset Value(s)
4th Apr 201811:21 amRNSCompliance with Market Abuse Regulation
3rd Apr 20189:38 amRNSTotal Voting Rights
29th Mar 20182:29 pmRNSTransaction in Own Shares
27th Mar 20183:49 pmRNSIssue of Equity
26th Mar 201811:41 amRNSNet Asset Value(s)
23rd Mar 20185:45 pmRNSTransaction in Own Shares
20th Mar 20185:23 pmRNSIssue of Equity
19th Mar 20183:15 pmRNSNet Asset Value(s)
19th Mar 20181:31 pmRNSHolding(s) in Company
13th Mar 20182:30 pmRNSTransaction in Own Shares
12th Mar 20183:07 pmRNSNet Asset Value(s)
9th Mar 20185:47 pmRNSIssue of a Supplementary Prospectus and Circular
2nd Mar 20185:03 pmRNSNet Asset Value(s)
1st Mar 201810:07 amRNSTotal Voting Rights
28th Feb 20188:02 amRNSIssue of Equity - replacement
27th Feb 20183:45 pmRNSDirector/PDMR Shareholding
27th Feb 20183:39 pmRNSIssue of Equity
26th Feb 20183:11 pmRNSNet Asset Value(s)
23rd Feb 20183:39 pmRNSTransaction in Own Shares
20th Feb 201811:00 amRNSNet Asset Value(s)
15th Feb 20182:02 pmRNSTransaction in Own Shares
12th Feb 20184:27 pmRNSNet Asset Value(s)
5th Feb 20181:46 pmRNSTransaction in Own Shares
2nd Feb 20182:38 pmRNSNet Asset Value(s)
1st Feb 20188:10 amRNSTotal Voting Rights
31st Jan 201810:07 amRNSDirector/PDMR Shareholding
30th Jan 20185:11 pmRNSIssue of Equity
29th Jan 20185:01 pmRNSNet Asset Value(s)
22nd Jan 20185:07 pmRNSNet Asset Value(s)
22nd Jan 201811:16 amRNSTransaction in Own Shares
19th Jan 201811:38 amRNSTransaction in Own Shares
18th Jan 201810:07 amRNSDirector Declaration
15th Jan 20184:53 pmRNSNet Asset Value(s)
4th Jan 20183:20 pmRNSNet Asset Value(s)
3rd Jan 20187:29 amRNSTotal Voting Rights
28th Dec 201710:26 amRNSTransaction in Own Shares
27th Dec 20177:00 amRNSNet Asset Value(s)
19th Dec 20174:39 pmRNSIssue of Equity
18th Dec 20174:15 pmRNSNet Asset Value(s)
18th Dec 201710:14 amRNSTransaction in Own Shares
11th Dec 20175:31 pmRNSNet Asset Value(s)
8th Dec 201712:25 pmRNSTransaction in Own Shares
6th Dec 201710:27 amRNSHolding(s) in Company
4th Dec 20174:22 pmRNSNet Asset Value(s)
1st Dec 20175:05 pmRNSTransaction in Own Shares
1st Dec 20179:27 amRNSTotal Voting Rights
29th Nov 201711:30 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.